The novel treatment of the medication represents a major breakthrough in the handling of the condition. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide692221.tusblogos.com/42767452/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment